🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the amount of GLPG0187 present in ...
Status
Completed
Location
SGS Stuivenberg
Start Date
2012-01
Trial ID
NCT01580644
Treatments Being Tested
Clinical investigation of anti-psoriatic efficacy and atrophy...
Status
Completed
Location
proDERM GmbH
Start Date
2014-03
Trial ID
NCT02111499
Treatments Being Tested
The primary purpose is to demonstrate the bioequivalence of naproxen admini...
Status
Completed
Location
Research Site
Start Date
2011-09
Trial ID
NCT01331993
Treatments Being Tested
The purpose of this study is to evaluate the safety, efficacy, and tolerabi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT00741884
This is a single centre, open-label, randomised, single dose, three-period,...
Status
Completed
Location
Simbec Research Ltd.
Start Date
2017-05-22
Trial ID
NCT03178214
Treatments Being Tested
MKC-NI-002 is a Phase 1b, randomized, double-blind, placebo-controlled stud...
Status
Completed
Location
VALDI
Start Date
2025-12-22
Trial ID
NCT07344558
Treatments Being Tested
This is a Phase 1, randomized, double-blinded, placebo-controlled, single a...
Status
Completed
Location
CMAX Clinical Research Pty Ltd
Start Date
2025-03-12
Trial ID
NCT06870058
Treatments Being Tested
The Zambia PCPI study will measure the effect of the parasite genotypes ass...
Status
Completed
Location
Nchelenge District
Start Date
2024-07-24
Trial ID
NCT06166498
Treatments Being Tested
The primary objective of the study is to evaluate efficacy of entospletinib...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2013-03-14
Trial ID
NCT01799889
Treatments Being Tested
PF-06651600 is being developed for treatment of inflammatory bowel disease....
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2016-02
Trial ID
NCT02684760
Treatments Being Tested